Shockwave Medical (SWAV) has a profit margin of 20.75%, above the Healthcare sector average of 14.34%.
Get informed when a big investor buys or sells
+ FollowAs of Mar 2024
Trailing 12 months ending Mar 2024
Shockwave Medical's profit margin stands at 20.75% as of March 2024. That compares with 43.18% in the prior-year period — down 51.9% year over year. That is above the Healthcare sector average of 14.34%. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.
Shockwave Medical reported 20.75% in profit margin versus 43.18% a year earlier — a 51.9% year-over-year decrease. The historical chart on this page makes it easier to see whether that move is part of a longer pattern.
Shockwave Medical sits higher the Healthcare benchmark (14.34%) with a profit margin of 20.75%. That is roughly 44.6% above the sector mean. Peer context matters because what looks expensive or cheap in absolute terms can be normal for the sector.
A profit margin of 20.75% for Shockwave Medical means each unit of related capital or sales is generating that return rate. Higher is usually better for profitability metrics, but extremely high figures can reflect one-time items or thin equity bases. Review several years of data on this page before extrapolating.
The history chart shows how Shockwave Medical's profit margin evolved across reporting periods, while the comparison chart places SWAV next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.